Search Results

Lenalidomide 200 mg  | 99.52%

TargetMol

Lenalidomide is a potent inhibitor of TNF-α that, at 10 μM, alters gene expression and cell viability in a range of cancer cell lines.

More Information Supplier Page

BS-181 hydrochloride 50 mg  | 99.97%

TargetMol

BS-181 HCl is a highly selective CDK7 inhibitor with IC50 of 21 nM. It is more than 40-fold selective for CDK7 than CDK1, 2, 4, 5, 6, or 9.

More Information Supplier Page

BS-181 hydrochloride 25 mg  | 99.97%

TargetMol

BS-181 HCl is a highly selective CDK7 inhibitor with IC50 of 21 nM. It is more than 40-fold selective for CDK7 than CDK1, 2, 4, 5, 6, or 9.

More Information Supplier Page